Tadalafil Improved Erectile Function at Twenty‐Four and Thirty‐Six Hours After Dosing in Men With Erectile Dysfunction: US Trial
- 6 May 2005
- journal article
- clinical trial
- Published by Wiley in Journal of Andrology
- Vol. 26 (3) , 310-318
Abstract
In a previous study assessing tadalafil for the treatment of erectile dysfunction (ED), tadalafil 20 mg was shown to improve erectile function for up to 36 hours vs placebo. This study sought to demonstrate the effectiveness of both 10‐ and 20‐mg tadalafil vs placebo at 2 prespecified assigned times of 24 and 36 hours postdosing. This double‐blind, placebo‐controlled, parallel‐group study randomized 483 men with ED into 6 groups according to a combination of treatment (placebo, tadalafil 10 or 20 mg) and assigned time (24 or 36 hours) for intercourse attempts. Patients were stratified by baseline ED severity based on Erectile Function Domain scores. The study had 4 phases: a 4‐week run‐in (no ED medication taken); a 2‐ to 4‐week equilibration (dosing as needed); a 4‐ to 6‐week assessment; and a 6‐month open‐label extension. During the assessment phase, men took a total of 4 doses of study medication, each dose separated by more than or equal to 7 days. Efficacy was measured as the mean per‐patient percentage of successful intercourse attempts (Sexual Encounter Profile Diary Question 3: SEP3) during the assessment phase. Men taking either 10‐ or 20‐mg tadalafil had a significant increase in SEP3 from baseline scores vs placebo at both 24 hours (P = .038 and <.001 for 10 and 20 mg, respectively) and 36 hours (P < .001 for both doses) postdose. The mean per‐patient percentages of successful intercourse attempts for the 24‐hour time point were 41.8%, 55.8%, and 67.3% for placebo and tadalafil 10 and 20 mg, respectively; for the 36‐hour time point, the mean per‐patient percentages were 32.8%, 56.2%, and 61.9% for placebo and tadalafil 10 and 20 mg, respectively. The most common treatment‐emergent adverse events were headache, back pain, dyspepsia, and nasopharyngitis. Both 10‐ and 20‐mg tadalafil improved erectile function for up to 36 hours postdosing in men with ED of varied severity.Keywords
This publication has 14 references indexed in Scilit:
- The efficacy and safety of tadalafil: an updateBJU International, 2004
- Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trialUrology, 2003
- Efficacy and Safety of Tadalafil for the Treatment of Erectile Dysfunction: Results of Integrated AnalysesJournal of Urology, 2002
- Molecular mechanism of cGMP-mediated smooth muscle relaxationJournal of Cellular Physiology, 2000
- The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequencesBJU International, 1999
- Sexual Dysfunction in the United StatesJAMA, 1999
- EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMESJournal of Urology, 1998
- ImpotenceJAMA, 1993
- Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic NeurotransmissionNew England Journal of Medicine, 1992
- Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscleBiochemical and Biophysical Research Communications, 1990